Target intelligence / Profile preview

Intestinal macrophage

Molecular classification
Other (Tissue-resident immune cell, Mononuclear phagocyte, Myeloid cell, not a molecular "target" like a receptor or enzyme)
01

Overview

Intestinal macrophages are specialized tissue-resident immune cells of the mononuclear phagocyte lineage found predominantly in the gut lamina propria, submucosa, and muscularis externa. They constitute the most abundant population of macrophages in the body and are critical for the maintenance of gut homeostasis. Their main functions include phagocytosis of pathogens and apoptotic cells, immune regulation, limiting inflammation, promoting wound healing, and facilitating crosstalk between immune, epithelial, neuronal, and vascular cells in the gastrointestinal tract. They differ from conventional macrophages in other tissues by their strong anti-inflammatory phenotype, ability to tolerate commensal bacteria, and niche-specific functional specialization. Aberrant macrophage responses are implicated in diseases such as IBD and other inflammatory or infectious diseases of the gut. However, “intestinal macrophage” is not a molecular target or receptor, but rather a physiological population of immune cells described by surface markers and location, and cannot be directly targeted in the way individual proteins or receptors are in drug development.

Other names
Gut macrophageLamina propria macrophageIntestinal tissue-resident macrophage
02

Biological functions

Immune responsePhagocytosis (uptake and clearance of pathogens, apoptotic cells, debris)Maintenance of immune tolerance to commensal bacteria and food antigensRegulation of inflammationTissue repair and wound healingCrosstalk with enteric neurons (modulation of gut motility and secretion)Maintenance of epithelial and vascular integrityRegulation of gut homeostasis
03

Disease associations

Inflammatory bowel disease (IBD, including Crohn’s disease and ulcerative colitis)Infection (gut-associated bacterial, viral, and parasitic infections)Inflammation (chronic and acute gut inflammation)Other gastrointestinal disorders (colitis, gut barrier dysfunction)
04

Safety considerations

Macrophage suppression may impair host defense and wound healing.Chronic over-activation/imbalance contributes to gut inflammation and tissue damage.Therapeutic modulation of intestinal macrophages risks disrupting gut immune tolerance or increasing susceptibility to infection and impaired barrier function
05

Biomarkers

CD64MERTKF4/80 (mouse)CD11bCD11cMHCIICD163CX3CR1Others used in subsets and species distinctions

Beyond the preview

Go deeper on Intestinal macrophage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal macrophage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call